Neustaedter said on LinkedIn that he started in his new role in the New York-based investment firm’s medical technologies practice this week.
August was his last month with Medtronic after a 14-year career, including seven years at Covidien before Medtronic bought it. It’s not clear who will replace him at Medtronic; the company has not responded to messages seeking more information.
PREVIOUSLY: Medtronic’s VC leader discusses risk, returns, strategy and an ‘ugly truth’
Deerfield reported more than $16.2 billion worth of assets under management for 10 clients identified as pooled investment vehicles in its latest disclosure wit…